Clinical trial
Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft…
NCT00003212 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00003212 |
|---|---|
| Title | Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma |
| Official title | Randomized Phase III Trial of Two Investigational Schedules of Ifosfamide vs. Standard Dose Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | doxorubicin hydrochloride, ifosfamide |
| Enrollment | 780 |
| Start date | Jan 1, 1998 |
| Primary completion | Nov 1, 2001 |
| First posted | Mar 12, 2004 |
| Last update posted | Jan 20, 2012 |
| Countries | Belgium, Denmark, France, Germany, Hungary, Netherlands, Poland, Slovakia, Spain, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: